Max Robotics — Global Service Robot Directory + US Certification

About

Federico Pierconti is a thoracic surgeon whose research centers on advancing minimally invasive surgical techniques for lung cancer, particularly through robotic-assisted lobectomy. His major contributions focus on improving perioperative outcomes and expanding the applicability of robotic surgery for early-stage non-small cell lung cancer (NSCLC). In his most cited work (15 citations), he demonstrated that robotic lobectomy with radical lymphadenectomy offers favorable oncological outcomes, challenging the historical gold standard of thoracotomy. He further refined surgical precision by developing fluorescence-guided techniques for identifying non-surface lung nodules during robotic resections (7 citations), addressing a key technical challenge. Pierconti also investigated the safety and efficacy of robotic lobectomy in elderly patients over 75 (6 citations), providing evidence that age alone should not preclude minimally invasive approaches. His pilot study on multimodal locoregional anesthesia (3 citations) explores innovative strategies to enhance postoperative pain management. Through these studies, Pierconti has helped establish robotic thoracic surgery as a safe, effective standard, particularly for vulnerable populations, while continuously seeking to improve patient recovery and surgical accuracy.